Clinical Experience

Asian Journal of Andrology (2007) 9, 129–133; doi:10.1111/j.1745-7262.2007.00227.x

Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders

Shih-Tsung Huang and Ming-Li Hsieh

Section of Andrology and Female Urology, Division of Urology, Department of Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University, College of Medicine, Taoyuan 333, Taiwan, China

Correspondence: Dr Shih-Tsung Huang, Division of Urology, Department of Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung College of Medicine, Taoyuan 333, Taiwan, China. Fax: +886-3-318-5116. E-mail: strong00@ms9.hinet.net

Received 18 April 2006; Accepted 12 July 2006.

Top

Abstract

Aim:

 

To determine if there are different penile hemodynamic patterns between sildenafil non-responders and responders by using color Doppler ultrasonography.

Methods:

 

A total of 69 erectile dysfunction (ED) patients aged 22–79 years were enrolled into the present study. Thirty-eight (55.1%) men with ED who did not respond to four attempts of treatment with 100 mg sildenafil after re-education were classified as sildenafil non-responders. A combination of three vasodilator drugs, 1.25 mg papaverine, 0.4 mg phentolamine and 5 mug prostaglandin E1, was given by intracavernous injection before penile Doppler ultrasonography was carried out. The erectile response to intracavernous injection and vascular parameters including peak systolic velocity (PSV), resistance index (RI), end diastolic velocity (EDV) and cavernosa artery diameter (CD) were measured and the results between sildenafil non-responders and responders were compared.

Results:

 

No statistical difference in vascular parameters measured by Doppler ultrasonography studies between non-responders and responders was noted. Sildenafil non-responders had a poorer penile rigidity response to intracavernous injection than responders (P < 0.05). Among patients with adequate PSV (greater than or equal to 30 cm/s) and abnormal EDV (> 5 cm/s), individuals in the non-responder group had fewer positive responses to intracavernous vasodilator injection than in the responder group (35.3% vs. 72.2%, P < 0.05). Advanced age and comorbidity with diabetes mellitus were significantly associated with sildenafil non-response (P < 0.05).

Conclusion:

 

Sildenafil non-responders were characterized by a poorer penile rigidity response to intracavernous injection and had an associated impaired veno-occlusive mechanism. Advanced age and comorbidity with diabetes mellitus were two common factors associated with non-response.

Keywords:

color Doppler ultrasonography, erectile dysfunction, impotence, sildenafil citrate, ultrasonography

Top

References

  1. Lue TF. Erectile dysfunction. N Engl J Med 2000; 342: 1802–13. | Article | PubMed | ISI | ChemPort |
  2. Yaman O, Tokatli Z, Akand M, Akand M, Elhan AH, Anafarta K. Characteristics of sildenafil erections in healthy young men. Asian J Androl 2005; 7: 395–8. | Article | PubMed | ChemPort |
  3. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–404. | Article | PubMed | ISI | ChemPort |
  4. Atiemo HO, Szostak MJ, Sklar GN. Salvage of sildenafil failures referred from primary care physicians. J Urol 2003; 170: 2356–8. | Article | PubMed | ISI |
  5. Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 2000; 55: 477–80. | Article | PubMed | ISI | ChemPort |
  6. Chiou RK, Pomeroy BD, Chen WS, Anderson JC, Wobig RK, Taylor RJ. Hemodynamic patterns of pharmacologically induced erection: evaluation by color Doppler sonography. J Urol 1998; 159: 109–12. | Article | PubMed | ISI | ChemPort |
  7. Broderick GA. Evidence based assessment of erectile dysfunction. Int J Impot Res 1998; 10: S64–73; discussion S77–69. | PubMed | ISI |
  8. Altinkilic B, Hauck EW, Weidner W. Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction. World J Urol 2004; 22: 361–4. | Article | PubMed |
  9. Copel L, Katz R, Blachar A, Sosna J, Sheiman RG. Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents - initial experience. Radiology 2005; 237: 986–91. | Article | PubMed |
  10. McCullough A, Woo K, Telegrafi S, Lepor H. Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP. Int J Impot Res 2002; 14: 462–5. | Article | PubMed | ChemPort |
  11. Mulhall J, Barnas J, Aviv N, Anderson M, Parker M. Sildenafil citrate response correlates with the nature and the severity of penile vascular insufficiency. J Sex Med 2005; 2: 104–8. | Article | PubMed | ChemPort |
  12. Pescatori ES, Hatzichristou DG, Namburi S, Goldstein I. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol 1994; 151: 1209–16. | PubMed | ChemPort |
  13. Martins FE, Padma-Nathan H. Diffuse veno-occlusive dysfunction. The underlying hemodynamic abnormality resulting in failure to respond to intracavernous pharmacotherapy. J Urol 1996; 156: 1942–6. | Article | PubMed | ChemPort |
  14. Elhanbly S, Schoor R, Elmogy M, Ross L, Hegazy A, Niederberger C. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis. J Urol 2002; 167: 192–6. | Article | PubMed |
  15. Gooren LJ, Saad F. Recent insights into androgen action on the anatomical and physiological substrate of penile erection. Asian J Androl 2006; 8: 3–9. | Article | PubMed | ChemPort |
  16. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–30. | PubMed | ChemPort |
  17. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF. Comprehensive evaluation of erectile dysfunction: do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003; 26: 1093–9. | Article | PubMed | ISI |
  18. El-Sakka AI. Penile axial rigidity and Doppler ultrasonography parameters in patients with erectile dysfunction: association with type 2 diabetes. Urology 2003; 62: 525–31. | Article | PubMed |
  19. Perimenis P, Konstantinopoulos A, Perimeni PP, Gyftopoulos K, Kartsanis G, Liatsikos E, Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. Asian J Androl 2006; 8: 219–24. | Article | PubMed | ChemPort |
  20. Wespes E, Rammal A, Garbar C. Sildenafil non-responders: haemodynamic and morphometric studies. Eur Urol 2005; 48: 136–9. | Article | PubMed | ChemPort |

Extra navigation

.

naturejobs

ADVERTISEMENT